摘要
背景:心血管疾病(CVD)是全球最常见的死亡原因,约占全世界死亡人数的30%。高血压是心血管疾病发病率和死亡率的常见因素。 方法和结果:脑血管病患者血浆铬粒素A(CGA)浓度升高,已建立的原发性高血压和心力衰竭(HF)患者血浆铬粒素A(CGA)浓度升高。连体在人原发性高血压中,CGA衍生肽的血浆水平(CST)降低。 CGA-TO-CST的低转换与患者死亡率升高有关急性心衰住院。与人类发现一致的是,cga基因敲除(chga-ko)小鼠缺乏cst,导致高血压的发展和补充cst对chga-ko小鼠的休息。矿石血压,暗示CST在调节高血压的关键作用。在外周系统中,CST通过刺激组胺释放,抑制儿茶酚胺分泌来降低血压。或引起血管扩张。中枢,CST通过刺激延髓尾侧腹外侧区(CVLM)和pyrami的GABA能神经元,改善压力反射敏感性(BRS)和心率变异性(HRV)。中央杏仁核的Dal神经元; CST还通过激发谷氨酸能延髓腹外侧延髓(RVLM)神经元减少BRS。 此外,CST通过抑制各向同性而提供心脏保护。D类软体动物;激活线粒体KATP通道,刺激再灌注损伤挽救激酶(Risk)和Survivin激活因子增强(安全)通路,从而抑制MI。线粒体渗透性过渡孔(MPTP)。cst通过直接抑制Ca2+/钙调素依赖性蛋白激酶Ⅱδ(CaMKIIδ)的活性及其还原作用来调节心肌细胞的Ca2+水平。N参与磷酸化磷脂和ryanodine受体2,从而为CST在衰竭心肌中的直接功能作用提供支持。 结论:这些多重效应使CST成为心血管功能的主要调节者。
关键词: 铬粒素A,肾上腺素能β-2受体,心肌病,心脏保护,心力衰竭,高血压,免疫细胞,烟碱-胆碱能受体。
Current Medicinal Chemistry
Title:Catestatin: A Master Regulator of Cardiovascular Functions
Volume: 25 Issue: 11
关键词: 铬粒素A,肾上腺素能β-2受体,心肌病,心脏保护,心力衰竭,高血压,免疫细胞,烟碱-胆碱能受体。
摘要: Background: Cardiovascular disease (CVD), the most common cause of death globally, accounts for ~30% of all deaths worldwide. Hypertension is a common contributor to morbidity and mortality from CVD.
Methods and Results: The plasma concentration of chromogranin A (CgA) is elevated in patients with CVD as well as patients with established human essential hypertension and heart failure (HF). In contrast, the plasma level of the CgA-derived peptide catestatin (CST) is diminished in human essential hypertension. Low conversion of CgA-to-CST has been associated with increased mortality in patients hospitalized with acute HF. Consistent with human findings, the lack of CST in CgA knockout (Chga-KO) mice eventuates in the development of hypertension and supplementation of CST to Chga-KO mice restores blood pressure, implicating CST as a key player in regulating hypertension. In the peripheral system, CST decreases blood pressure by stimulating histamine release, inhibiting catecholamine secretion, or causing vasodilation. Centrally, CST improves baroreflex sensitivity (BRS) and heart rate variability (HRV) by exciting GABAergic neurons in the caudal ventrolateral medulla (CVLM) and pyramidal neurons of the central amygdala; CST also decreases BRS by exciting glutamatergic rostral ventrolateral medulla (RVLM) neurons. In addition, CST provides cardioprotection by inhibiting inotropy and lusitropy; activating mitochondrial KATP channels, and stimulating reperfusion injury salvage kinase (RISK) and survivor activating factor enhancement (SAFE) pathways and consequent inhibition of mitochondrial permeability transition pore (mPTP). CST modulates cardiomyocyte Ca2+ levels by direct inhibition of Ca2+/calmodulin-dependent protein kinase IIδ (CaMKIIδ) activity and consequent reduction in phosphorylation of phospholamban and ryanodine receptor 2, thereby providing support for a direct functional role of CST in the failing myocardium.
Conclusion: These multitude of effects establish CST as a master regulator of cardiovascular functions.
Export Options
About this article
Cite this article as:
Catestatin: A Master Regulator of Cardiovascular Functions, Current Medicinal Chemistry 2018; 25 (11) . https://dx.doi.org/10.2174/0929867324666170425100416
DOI https://dx.doi.org/10.2174/0929867324666170425100416 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthesis and Biological Activity of Prostaglandin Analogs Containing Heteroatoms in the Cyclopentane Ring
Current Organic Chemistry HspB5/αB-Crystallin: Properties and Current Progress in Neuropathy
Current Neurovascular Research Adipose Tissue Derived Stem Cells Secretome: Soluble Factors and Their Roles in Regenerative Medicine
Current Stem Cell Research & Therapy Effects of Melatonin on Ischemic Spinal Cord Injury Caused by Aortic Cross Clamping in Rabbits
Current Neurovascular Research Diabetes Exacerbates Nanoparticles Induced Brain Pathology
CNS & Neurological Disorders - Drug Targets Recent Trials for FTY720 (Fingolimod): A New Generation of Immunomodulators Structurally Similar to Sphingosine
Reviews on Recent Clinical Trials Combination of Photodynamic Therapy with Anti-Cancer Agents
Current Medicinal Chemistry Disease-Related Changes in TRPV1 Expression and Its Implications for Drug Development
Current Topics in Medicinal Chemistry Bradykinin Receptors in Ischemic Injury
Current Neurovascular Research Reactive Oxygen Species, Vascular Disease and Cardiovascular Surgery
Current Vascular Pharmacology OPA1 in Cardiovascular Health and Disease
Current Drug Targets An Optimal Combination of Chemically Pure Compounds from <i>Salvia miltiorrhiza</i> for Inhibiting Cell Proliferation
Cardiovascular & Hematological Agents in Medicinal Chemistry Lung Transplantation: The Role of Azithromycin in the Management of Patients with Bronchiolitis Obliterans Syndrome
Current Medicinal Chemistry Calpain Inhibition: A Therapeutic Strategy Targeting Multiple Disease States
Current Pharmaceutical Design Cytoprotective Strategy Against Pulmonary Fibrosis
Drug Design Reviews - Online (Discontinued) Diabetes Mellitus: Channeling Care through Cellular Discovery
Current Neurovascular Research NGS of microRNAs Involved in Cardioprotection Induced by Sevoflurane Compared to Propofol in Myocardial Revascularization Surgery: The ACDHUVV-16 Clinical Trial
Current Medicinal Chemistry Heart Failure Models: Traditional and Novel Therapy
Current Vascular Pharmacology Antioxidant Treatment and Endothelial Dysfunction: Is it Time for Flavonoids?
Recent Patents on Cardiovascular Drug Discovery Neuroprotective Effects of a Glutathione Depletor in Rat Post-Ischemic Reperfusion Brain Damage
CNS & Neurological Disorders - Drug Targets